Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lot's to like here!!
Dilutive financing ended
Important patent approval achieved
Deep patent portfolio and pipeline
Insider buying
Huge market potential
Reasonable cash position
Accumulation underway .012-.015
Go - mighty Titans :)
My bad - wrong board - sry
10Q should be out any day - correct?
10Q should be out any day - correct?
"A man doesn't know what he knows until he knows what he doesn't know"
Strange trading - my buy order is getting filled in 5000 share blocks nothing bigger?
BTW .013 was the ask when I placed the order.
"A man doesn't know what he knows until he knows what he doesn't know"
Newsletter Phantom GS.
http://www.phantom-gs.com/newsletter/october2008/index.html
Actually yes, but the common shareholder will realize no benefit as YA owns this co lock, stock, and barrel. What percentage of the float will be held by current stockholders if YA converts in Feb and the share conversion price is -- oh let's say .001?
"A man doesn't know what he knows until he knows what he doesn't know"
Updated with most recent information -- Fixed formula error on principal received - total. Announced but not yet received financings excluded from totals. Interest accumulation for Series C is estimated because I am unable to determine total carry due to ongoing conversions.
OK I'm finished now GLTA
Regards,
"A man doesn't know what he knows until he knows what he doesn't know"
I'm no expert, but that would appear to be the case.
Sure wish I could come up with a way to see to it that YA ends up with nothing for their 50mm investment just like the common shareholders will.
Go EFF
Barcodes suck -- who needs em.
Papa Johns -- no thanks!
Ralph Lauren -- Don't think so!
Venting a little!! -- sorry
"A man doesn't know what he knows until he knows what he doesn't know"
They have been converting at less than .01 for a long time. I'm not sure, but for the purpose of voting shares it looks like par is the minimum "as converted" value. I was just trying to determine how the company came up with the 3.2b number of voting shares and that is my assumption.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=31843085
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=32804332
"A man doesn't know what he knows until he knows what he doesn't know"
Each share of Series C carries voting power on an "as converted" basis. $19,307,000 converted at a par value (minimum conversion price) of .01 = 1,930,700,000 votes but if the same value was converted at a par value of .0001 there would be 193,070,000,000. Since current share price is around .003 the conversion would currently equal 6,435,666,667 shares/votes. The number of votes "on an as converted basis" will change with the stock price but apparently cannot go below par value. Whether this is accomplished via RS or increase in AS the results would be the same. What difference does a vote make if the vote is predetermined? It's anyones guess as to what PPS will be in Feb, but it's fair to say that it will be whatever YA wants it to be. All IMO of course!
Regards,
"A man doesn't know what he knows until he knows what he doesn't know"
· At the option of the holders, if there are outstanding shares of Series C Convertible Preferred Stock on February 17, 2009, each share of Series C Preferred Stock shall convert into shares of common stock at the conversion price then in effect on February 17, 2009
http://ih.advfn.com/p.php?pid=nmona&cb=1223576618&article=28623303&symbol=NB%5ENEOM
If YA should choose to waive the self imposed 4.99% ownership limitation and convert all of the Series C shares in Feb, they can assume direct ownership of more than 90% of the OS and still hold all the assets via the SPA agreements. Of course this would require an increase in AS to somewhere north of 20 billion shares. They will certainly have the voting power to do it if they choose to. Then if the company were sold they would be in line for a bigger piece of the pie than simply being repaid for the outstanding debt. Just speculating here, someone tell my why I'm wrong. Please!!
Regards,
Companys calculations on total voting shares.
3,230,944,960
Current outstanding = 1,300,244,960
Series C preferred = 19,307 - face value of 19,307,000 divided by current par value of .01 = 1,930,700,000
1,300,244,960
1,930,700,000
3,230,944,960 = company's statement of voting shares,= YA controls the vote, period.
If they keep converting at 150mm/qtr using series C and .01 par they would loose control in the not too distant future but at .0001 par value they will have 100 times the voting shares.
"A man doesn't know what he knows until he knows what he doesn't know"
You are here: Press > Press releases > By date > 2008
Press release 08/21/2008
Note Regarding Shareholder Conference Call
The call scheduled on September 17 will be an “information only” call; there will not be a question & answer period. We are scheduling a Shareholder Meeting before the end of the year and shareholder questions will be welcomed during that forum.
http://www.neom.com/84.html
"A man doesn't know what he knows until he knows what he doesn't know"
BUYINS.NET: BIPH, ATDVF, GNLAF, VSTL, NILSY, SCGLY Have Also Been Removed From Naked Short List Today
Tuesday October 07, 2008 09:52:13 EDT
Oct 07, 2008 (M2 PRESSWIRE via COMTEX News Network) --
BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: Biophan Technologies Inc (OTCBB:BIPH), Austin Developments Corp. (OTC:ATDVF), Genesis Land Development Corp. (OTC:GNLAF), Vistula Communications Services Inc. (OTC: VSTL), GMK Noril'skiy nikel' OAO (OTC:NILSY), Societe Generale France Sponsored ADR (OTC:SCGLY). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.
Biophan Technologies Inc (OTCBB:BIPH) through its subsidiaries, engages in the research and development of technologies for use with medical procedures and biomedical devices. Its technologies enable biomedical devices, both implantable and those used in diagnostic and interventional procedures, to be safe and image compatible with magnetic resonance imaging (MRI). The company is also developing and marketing a system for generating power for implantable devices from body heat; and a series of implantable devices, including MRI-visible vascular implants, such as a vena cava filter, a heart valve, and an occluder for the treatment of atrial septal defects, a hole in the wall separating the left and right chambers of the heart. In addition, Biophan Technologies, through its interest in Myotech, LLC, develops the MYO-VAD, a cardiac assist device for treating multiple types of acute and chronic heart failure, including congestive heart failure and sudden cardiac arrest. It also licenses its technologies to Boston Scientific. The company was founded in 1963 and is headquartered in Pittsford, New York. With 134.04 million shares outstanding and 180,900 shares declared short as of September 2008, there is no longer a failure to deliver in shares of BIPH. According to quarterly data provided by the SEC, there were still 1,745,035 shares of BIPH that were failing-to-deliver as of June 5, 2008.
http://www.quote.com/news/story.action?id=MTO281u7402
BIPH holding up pretty well given the circumstances.
IMO, it is unlikely that we will see anything definitive on the patent reexam forthcoming with the next office action. It is more likely that another round of responses will ensue or that the action is made final prompting an appeal.
"A man doesn't know what he knows until he knows what he doesn't know"
Quarterly filing reported OS =1,145,224,960
Current filing reported OS = 1,300,244,960
Dilution since last 10Q = 155,020,000
SAD!
This is my most recent estimate of share structure using information just provided. Current AS is almost gone. We will have an increase in AS or a RS without question IMO. One or the other is going to happen. Not sure which I would prefer.
Mobile Barcodes At the airport with Iain McCready CEO Neo Media
"I have a strong team that will grow. Excellent backing and everyone in the company knows that we are sitting on the cusp of something huge".
"I am so confident. I speak to so many people on a daily basis. There is no point in shouting and screaming and finger pointing. At the end of the day we are a company with the patents and with a vision and with people that have created data matrix codes".
"We are in a promising position now and the most amazing brands such as Ralph Lauren are using our services. This is leadership at every level".
"We are not in breach of any patents. We don’t have a business model that relies on other people’s technology and we are very proud of that".
"The world is our oyster. We are strategically in the best position in the market. We have a backpocket full of patents. We are not aggressive –but we are in favour of relationships with everyone. Our dream is for mobile barcodes everywhere and with that vision – we will progress."
http://www.gomonews.com/mobile-barcodes-at-the-airport-with-iain-mccready-ceo-neo-media/
That office action was mailed on 6/30/08 and the applicant had 3 months to respond. No indication of a response on patent office website. Appears as if the application may have been abandoned. I will keep an eye on it for any updates.
And here is the current status of the application from the USPTO website.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=31800799
Here's a little additional conformation for you. Significant indeed, this patent looked to be DOA a week ago!
Is the Transfer Agent gagged? Anyone tried calling lately?
Here you go--application # 10607434
http://portal.uspto.gov/external/portal/pair
This is big news for the CSS patent portfolio!!
Patent Application Information Retrieval
10/607,434 SENSOR-EQUIPPED AND ALGORITHM-CONTROLLED DIRECT MECHANICAL VENTRICULAR ASSIST DEVICE
Bibliographic Data
Application Number: 10/607,434 Customer Number: -
Filing or 371 (c) Date: 06-26-2003 Status: Allowed -- Notice of Allowance Not Yet Mailed
Application Type: Utility Status Date: 10-02-2008
Examiner Name: OROPEZA, FRANCES P Location: ELECTRONIC
Group Art Unit: 3766 Location Date: -
Confirmation Number: 5213 Earliest Publication No: US 2004-0267086 A1
Attorney Docket Number: 034448-007 Earliest Publication Date: 12-30-2004
Class / Subclass: 600/017 Patent Number: -
First Named Inventor: Mark Anstadt , Augusta, GA Issue Date of Patent: -
--------------------------------------------------------------------------------
Title of Invention: SENSOR-EQUIPPED AND ALGORITHM-CONTROLLED DIRECT MECHANICAL VENTRICULAR ASSIST DEVICE
37 CFR 1.311 Notice of Allowance.
(a) If, on examination, it appears that the applicant is entitled to a patent under the law, a notice of allowance will be sent to the applicant at the correspondence address indicated in § 1.33. The notice of allowance shall specify a sum constituting the issue fee which must be paid within three months from the date of mailing of the notice of allowance to avoid abandonment of the application. The sum specified in the notice of allowance may also include the publication fee, in which case the issue fee and publication fee (§ 1.211(e)) must both be paid within three months from the date of mailing of the notice of allowance to avoid abandonment of the application. This three-month period is not extendable.
sunspotter, I'm pretty new to this stock myself, guess that makes me a newbie, anyway just thought I would point out that all seasoned investors have a strategy and that strategy may or may not be in line with your own. Has it always been your nature to attempt to ridicule viewpoints that are different than your own? Perhaps you should lay it out for all us newbie investors here. What is the correct investment strategy in BIPH in order to realize a return on investment? Perhaps you already tried to deploy your viewpoint and are now bitter because it didn't work as you had hoped.
My strategy is to seek long term investments in start up companies with large potential markets, patented intelectual property, seasoned management, and transparency. I sometimes get into something I wish I never had, and sometimes I make a hasty exit at a loss when my own DD turns up something I didn't know. Ok that's out of the way -- on with the meaningful discussion please!
Regards,
The patent application submitted by Dr. Botte appears to be nearing issue. The document below indicates that most of the claims have been allowed and negotiations continue on the balance. There are also 5 subordinate applications filed in 2008 relating to this patent application.
Well, it sounds like they are very low on capital but he believes they have a great product. Apparently several here question his credibility and would know better than me. I liked his optimism regarding future PPS.
P.S. I've been looking for patent information and cannot find any.
Regards,
Thanks for the effort and thanks for posting.
Kinda dead on this MB need some enthusiasm here!!
It looks like BIPH is experiencing some delays getting the CSS patents cleared through the USPTO. That factor is probably what is holding up the further development into human trials. IMO and FWIW
Sorry dated article -- I removed the post.
Local article
http://www.democratandchronicle.com/article/20080925/BUSINESS/809250335
BIPH - Pittsford's Biophan sheds its debts, improves deal prospects
Investors are suddenly more bullish about Biophan Technologies Inc., a struggling Pittsford biomedical device firm, as the company said Wednesday that it has shed a sizable amount of debt.
Biophan shares closed at 3 cents, up nearly 2 cents for the day.
The company has spent most every day this year trading at under 10 cents and has been trading at a penny since Sept. 3.
Wednesday's small jump in share price came as Biophan announced it had paid off $2.3 million in debt held by a variety of hedge funds. The company used a combination of 18 million shares and $2.15 million in cash.
Biophan had been required to pay off its debt in shares of stock, so that $2.3 million would have required issuing 230 million shares at a penny per share, Chief Executive John Lanzafame said. "This is a far less dilutive alternative."
The debt was due in October 2009.
The agreement also cancels a subscription warrant that let the hedge funds purchase another 17 million shares, according to Biophan.
Biophan said the deal leaves it with enough money on hand for 12 months of operation, but Lanzafame said the company intends to find bridge financing or develop the business to begin taking in revenues.
Biophan had been required to issue stock monthly to the hedge funds, and that monthly sale was depressing the share price, Lanzafame said.
Being out of the debt arrangement also gets the company out from under some control provisions and "really frees us up to do different types of deals with our technology," he said.
Biophan is working on a variety of cardiac technology, such as stents that do not interfere with MRIs and a pump that would supplement the heart in treatment of acute heart failure.
MDANEMAN@DemocratandChronicle.com
Someone is in denial!!
Throughout the year the Company converted $29,210 of its convertible debentures into
35,061,636 shares of the Company’s common stock. (.0008 ea)
The Company is authorized to issue 100,000,000 shares of preferred stock. As of July 31, 2007,
no shares were issued or outstanding.
In April the company raised its common stock authorized to 2,500,000,000 shares.
Page 17
http://www.crystalitg.com/july%2031%202008%20CINT%20Financials.pdf
Hmmm -- you don't believe the co's number provided in their financial statement? I am asking where the 500mm number in the I-box came from, anyone know? Transfer agent I presume.
Guess I'll just wait to see if they come through with updated financials, as promised, cause I'm confused and skeptical at this point.
I have a couple of serious questions here. I've been watching this one for awhile and want to join the party but I am hesitant because of the following.
Why does the I box show the Authorized shares at 500mm and the financial statement from the website show AS at 2.5 billion?
STOCKHOLDERS' EQUITY
Common stock; par value $.001; 2,500,000,000 shares authorized,
161,927,562 issued and outstanding
http://www.crystalitg.com/investors.php
I've also seen repeated posts of no dillution but wonder how that can be when the financials from the website dated 7-31-08
show OS at 161,927,562 and an update from the company on 8-08-08 shows OS of 215,660,159
http://biz.yahoo.com/iw/080909/0431961.html
I think this has been updated too.
http://neoreader.com/43.html